James Investment Research’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-67
Closed -$33K 386
2023
Q1
$33K Sell
67
-134
-67% -$66.2K ﹤0.01% 399
2022
Q4
$103K Buy
+201
New +$106K 0.01% 296
2021
Q3
Sell
-53
Closed -$24K 514
2021
Q2
$24K Sell
53
-1
-2% -$437 ﹤0.01% 431
2021
Q1
$23K Sell
54
-44
-45% -$17.6K ﹤0.01% 417
2020
Q4
$41K Sell
98
-2,314
-96% -$962K ﹤0.01% 398
2020
Q3
$998K Sell
2,412
-456
-16% -$183K 0.09% 160
2020
Q2
$1.11M Sell
2,868
-268
-9% -$100K 0.1% 147
2020
Q1
$984K Sell
3,136
-6,759
-68% -$2.28M 0.1% 132
2019
Q4
$3.63M Sell
9,895
-1,547
-14% -$491K 0.25% 111
2019
Q3
$2.92M Sell
11,442
-1,637
-13% -$459K 0.21% 113
2019
Q2
$3.47M Buy
13,079
+9,779
+296% +$2.48M 0.25% 101
2019
Q1
$878K Sell
3,300
-1,662
-33% -$479K 0.06% 232
2018
Q4
$1.42M Sell
4,962
-1,931
-28% -$612K 0.09% 196
2018
Q3
$2.33M Sell
6,893
-2,545
-27% -$827K 0.1% 221
2018
Q2
$2.81M Buy
9,438
+145
+2% +$42.5K 0.11% 193
2018
Q1
$2.5M Buy
9,293
+3,436
+59% +$930K 0.09% 211
2017
Q4
$1.45M Sell
5,857
-1,673
-22% -$413K 0.05% 443
2017
Q3
$1.83M Buy
+7,530
New +$1.84M 0.06% 295

Other funds holding HUM

James Investment Research's HUM Position: Q2 2023 in Review

James Investment Research sold out of Humana (HUM) in Q2 2023, closing a stake of 67 shares — an estimated $33K sold.

James Investment Research first reported a position in HUM in Q3 2017 and held it in 18 quarters. The position peaked at $3.63M in Q4 2019. 1,070 funds tracked by Wall St. Rank hold HUM as of Q2 2023.

  • James Investment Research reported no remaining Humana position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 67 Humana shares in Q2 2023, an estimated $33K.
  • James Investment Research first reported a position in Humana in Q3 2017 and held it in 18 quarters.
  • James Investment Research's Humana position peaked at $3.63M in Q4 2019.
  • 1,070 funds tracked by Wall St. Rank held Humana as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.